Time limited offer for new users ▶ Get up to 3 months free

Serving leading biopharmaceutical companies globally:

Express Scripts
Dow
Medtronic
Harvard Business School
McKesson
Mallinckrodt

Last Updated: February 4, 2023

Ferric derisomaltose - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What are the generic sources for ferric derisomaltose and what is the scope of patent protection?

Ferric derisomaltose is the generic ingredient in one branded drug marketed by Pharmacosmos As and is included in one NDA. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Ferric derisomaltose has forty-one patent family members in twenty-five countries.

One supplier is listed for this compound.

Summary for ferric derisomaltose
International Patents:41
US Patents:2
Tradenames:1
Applicants:1
NDAs:1
Finished Product Suppliers / Packagers: 1
Raw Ingredient (Bulk) Api Vendors: 4
Clinical Trials: 17
Patent Applications: 8
What excipients (inactive ingredients) are in ferric derisomaltose?ferric derisomaltose excipients list
DailyMed Link:ferric derisomaltose at DailyMed
Recent Clinical Trials for ferric derisomaltose

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Alberta Health Services, CalgaryPhase 3
AHS Cancer Control AlbertaPhase 3
University of MichiganPhase 3

See all ferric derisomaltose clinical trials

US Patents and Regulatory Information for ferric derisomaltose

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmacosmos As MONOFERRIC ferric derisomaltose SOLUTION;INTRAVENOUS 208171-002 Jan 16, 2020 DISCN Yes No See Plans and Pricing See Plans and Pricing Y Y See Plans and Pricing
Pharmacosmos As MONOFERRIC ferric derisomaltose SOLUTION;INTRAVENOUS 208171-003 Jan 16, 2020 RX Yes Yes See Plans and Pricing See Plans and Pricing Y Y See Plans and Pricing
Pharmacosmos As MONOFERRIC ferric derisomaltose SOLUTION;INTRAVENOUS 208171-002 Jan 16, 2020 DISCN Yes No See Plans and Pricing See Plans and Pricing Y Y See Plans and Pricing
Pharmacosmos As MONOFERRIC ferric derisomaltose SOLUTION;INTRAVENOUS 208171-001 Jan 16, 2020 DISCN Yes No See Plans and Pricing See Plans and Pricing Y Y See Plans and Pricing
Pharmacosmos As MONOFERRIC ferric derisomaltose SOLUTION;INTRAVENOUS 208171-003 Jan 16, 2020 RX Yes Yes See Plans and Pricing See Plans and Pricing Y Y See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for ferric derisomaltose

Country Patent Number Title Estimated Expiration
Denmark 2411053 See Plans and Pricing
Spain 2617658 See Plans and Pricing
Hong Kong 1164138 穩定的鐵寡糖複合物 (A STABLE IRON OLIGOSACCHARIDE COMPOUND) See Plans and Pricing
Canada 2756580 COMPOSE OLIGOSACCHARIDE STABLE ASSOCIE AU FER (A STABLE IRON OLIGOSACCHARIDE COMPOUND) See Plans and Pricing
European Patent Office 2411053 COMPOSÉ OLIGOSACCHARIDE STABLE ASSOCIÉ AU FER (A STABLE IRON OLIGOSACCHARIDE COMPOUND) See Plans and Pricing
>Country >Patent Number >Title >Estimated Expiration

Supplementary Protection Certificates for ferric derisomaltose

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2411053 C02411053/01 Switzerland See Plans and Pricing PRODUCT NAME: FERRUM (III) UT FERRI ISOMALTOSIDUM; REGISTRATION NO/DATE: SWISSMEDIC-ZULASSUNG 67001 26.08.2019
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Colorcon
Baxter
AstraZeneca
Dow
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.